Mark Stevenson
Director/Board Member at INGERSOLL RAND INC.
Net worth: 668 782 $ as of 2024-04-29
News on Mark Stevenson
Linked companies
| Listed companies | 2 |
|---|---|
| THERMO FISHER SCIENTIFIC | Health Technology |
| INGERSOLL RAND INC. | Producer Manufacturing |
| Private companies | 8 |
|---|---|
The Park National Bank (Investment Management)
 The Park National Bank (Investment Management) Investment ManagersFinance The Park National Bank (Investment Management) (PNB-IM) is the investment management division of The Park National Bank (PNB), which is headquartered in Newark, Ohio. The firm is a subsidiary of Park National Corp. (NYSE: PRK), a bank holding company. PNB-IM was founded in 1908 and manages separate portfolios for individuals and institutions. In addition to general banking and trust business, the affiliated county seat banks in the corporation also provide specialized financial services including aircraft leasing, municipal finance, and consumer lending. | Finance |
Applera Corp.
 Applera Corp. Medical SpecialtiesHealth Technology Applera Corp. manufactures medical instruments | Health Technology |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Commercial Services |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
Personalized Medicine Coalition
 Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry. | Commercial Services |
General Atlantic LLC
 General Atlantic LLC Investment ManagersFinance General Atlantic LLC (General Atlantic) is a private equity firm founded in 1980 by Charles F. Feeney. The firm is headquartered in New York. | Finance |
Harbinger Health
 Harbinger Health Information Technology ServicesTechnology Services Harbinger Health, Inc. is a company based in Cambridge, MA. Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis, and management. The company combines advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing a low-cost, multi-cancer blood test. Harbinger envisions a future where cancer could be kept from forming, making a cancer diagnosis a routine health problem to be addressed rather than a life-altering event to be feared with profound implications for people, healthcare systems, and societies. The company fundamentally transforms cancer care for everyone. The company was founded in 2020 by Alexander Meissner, Sidney Farber, Zachary Smith, Franziska Michor. The CEO is Stephen Hahn. | Technology Services |
Training of Mark Stevenson
| The University of Reading | Undergraduate Degree |
| Henley Management College | Masters Business Admin |